OICR News / Tag

Molecular Pathology

Browse news tagged Molecular Pathology.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Collaboration

OICR and OMPRN celebrate International Pathology Day with educational events

On November 16 OICR and the Ontario Molecular Pathology Research Network (OMPRN) joined other organizations around the world celebrating International Pathology Day. A special Café Scientifique was held entitled, “Beyond the crime scene: You don’t…

ArticleNov 23, 2016

Collaboration

International Pathology Day 2016

Today is International Pathology Day. Around the world and here in Ontario events will be held to raise awareness of the field and its contributions to modern medicine. The work of the Transformative Pathology Program,…

ArticleNov 16, 2016

Collaboration

Beyond the crime scene: You don’t have to be dead to need a pathologist

Dr. John Bartlett, from the Ontario Institute for Cancer Research, and Dr. Michelle Downes, from Sunnybrook Health Science Centre, will take you into a world of pathology beyond crime scene investigation and into puzzles more…

ArticleNov 04, 2016

Collaboration

Pathology Matters: One attendee’s reflections on OMPRN’s first gathering of Ontario pathologists

Dr. Matt Cecchini was one of many pathologists and researchers, including 21 trainees, to attend the inaugural Pathology Matters meeting hosted by the Ontario Molecular Pathology Research Network (OMPRN). In this post he covers what…

ArticleOct 28, 2016

TechnologyPancreatic cancer

OICR’s Transformative Pathology Program contributes to recent PanCuRx findings

Ilinca Lungu, a Research Technician in OICR's Transformative Pathology Program, talks about her group's contributions to recent findings from the PanCuRx Translational Research Initiative. Access to the Transformative Pathology Program's resources and expertise is available…

ArticleOct 27, 2016

TechnologyTreatment

OICR-led study finds four unique genomic signatures in pancreas cancer, uncovers potential of immunotherapies

Pancreas cancer is one of the most aggressive and deadly forms of the disease. According to the Canadian Cancer Society, only 8 percent of pancreas cancer patients survive more than five years after diagnosis. OICR’s…

ArticleOct 21, 2016

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.